• Je něco špatně v tomto záznamu ?

Acipimox during exercise points to an inhibitory feedback of GH on ghrelin secretion in bulimic and healthy women

J. Nedvidkova, K. Smitka, H. Papezova, K. Vondra, M. Hill, V. Hainer

. 2011 ; 167 (1) : 134-139. [pub] 20110113

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027126

OBJECTIVE: Ghrelin is predominantly produced by the stomach and the growth hormone (GH)-ghrelin feedback loop between the stomach and the pituitary gland has recently been suggested. The disruption of the gut-brain axis might be involved in bulimia nervosa (BN). METHODS: We investigated responses of plasma GH, ghrelin, and neuropeptide Y (NPY) concentrations to exercise or to exercise after the administration of the antilipolytic drug Acipimox (Aci) in seven BN patients and seven healthy women (C). Aci was administered 1h before exercise (45 min, 2 W/kg of lean body mass/LBM/). Ghrelin, GH, NPY, free fatty acids (FFA) and glycerol plasma levels were measured during the test using commercial kits. RESULTS: The exercise induced an increase in plasma GH, NPY and FFA in both groups and a decrease in plasma ghrelin levels only in BN patients. Exercise after Aci administration resulted in an increase in plasma GH, and a decrease in plasma ghrelin in both groups; NPY increased more in BN patients. Exercise-induced FFA increase was depressed after Aci. CONCLUSIONS: We conclude that the Aci-induced suppression in plasma ghrelin levels during exercise in both groups suggests a negative feedback of GH on ghrelin secretion. Observed changes in plasma FFA levels were not related to changes in GH and ghrelin levels.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027126
003      
CZ-PrNML
005      
20160417111941.0
007      
ta
008      
120816s2011 ne f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.regpep.2010.12.012 $2 doi
035    __
$a (PubMed)21237212
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Nedvídková, Jara, $d 1938- $7 jk01082905 $u Institute of Endocrinology, Narodni 8, 116 94 Prague 1, Czech Republic. jnedvidkova@endo.cz
245    10
$a Acipimox during exercise points to an inhibitory feedback of GH on ghrelin secretion in bulimic and healthy women / $c J. Nedvidkova, K. Smitka, H. Papezova, K. Vondra, M. Hill, V. Hainer
520    9_
$a OBJECTIVE: Ghrelin is predominantly produced by the stomach and the growth hormone (GH)-ghrelin feedback loop between the stomach and the pituitary gland has recently been suggested. The disruption of the gut-brain axis might be involved in bulimia nervosa (BN). METHODS: We investigated responses of plasma GH, ghrelin, and neuropeptide Y (NPY) concentrations to exercise or to exercise after the administration of the antilipolytic drug Acipimox (Aci) in seven BN patients and seven healthy women (C). Aci was administered 1h before exercise (45 min, 2 W/kg of lean body mass/LBM/). Ghrelin, GH, NPY, free fatty acids (FFA) and glycerol plasma levels were measured during the test using commercial kits. RESULTS: The exercise induced an increase in plasma GH, NPY and FFA in both groups and a decrease in plasma ghrelin levels only in BN patients. Exercise after Aci administration resulted in an increase in plasma GH, and a decrease in plasma ghrelin in both groups; NPY increased more in BN patients. Exercise-induced FFA increase was depressed after Aci. CONCLUSIONS: We conclude that the Aci-induced suppression in plasma ghrelin levels during exercise in both groups suggests a negative feedback of GH on ghrelin secretion. Observed changes in plasma FFA levels were not related to changes in GH and ghrelin levels.
650    _2
$a dospělí $7 D000328
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a bulimia nervosa $x krev $x patofyziologie $7 D052018
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a cvičení $x fyziologie $7 D015444
650    _2
$a kyseliny mastné neesterifikované $x krev $7 D005230
650    _2
$a zpětná vazba fyziologická $7 D025461
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ghrelin $x biosyntéza $x sekrece $7 D054439
650    _2
$a glycerol $x krev $7 D005990
650    _2
$a experimenty na lidech $7 D006805
650    _2
$a lidský růstový hormon $x biosyntéza $x sekrece $7 D019382
650    _2
$a lidé $7 D006801
650    _2
$a hypolipidemika $x aplikace a dávkování $7 D000960
650    _2
$a neuropeptid Y $x krev $7 D009478
650    _2
$a hypofýza $x účinky léků $x sekrece $7 D010902
650    _2
$a pyraziny $x aplikace a dávkování $7 D011719
650    _2
$a žaludek $x účinky léků $x metabolismus $7 D013270
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Smitka, Kvido, $d 1965- $7 xx0139475 $u Institute of Endocrinology, Narodni 8, 116 94 Prague 1, Czech Republic
700    1_
$a Papežová, Hana, $d 1953- $7 jn20001005414 $u Psychiatric Clinic, First Faculty of Medicine, Charles University, Ke Karlovu 11, 120 00 Prague 2, Czech Republic
700    1_
$a Vondra, Karel, $d 1943- $7 jo20000074105 $u Institute of Endocrinology, Narodni 8, 116 94 Prague 1, Czech Republic
700    1_
$a Hill, Martin, $d 1962- $7 mzk2005304431 $u Institute of Endocrinology, Narodni 8, 116 94 Prague 1, Czech Republic
700    1_
$a Hainer, Vojtěch, $d 1944- $7 jn19990209207 $u Institute of Endocrinology, Narodni 8, 116 94 Prague 1, Czech Republic
773    0_
$w MED00010523 $t Regulatory peptides $x 1873-1686 $g Roč. 167, č. 1 (2011), s. 134-139
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21237212 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160417112028 $b ABA008
999    __
$a ok $b bmc $g 949168 $s 784472
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 167 $c 1 $d 134-139 $e 20110113 $i 1873-1686 $m Regulatory peptides $n Regul Pept $x MED00010523
LZP    __
$b NLK122 $a Pubmed-20120816/11/02

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace